Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8859cb0f0a243827ac7b5ab6ddc23d57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ecc01dbbe855d729f0c7d68a3e5cd8a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate |
2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39513daa2ce62080fa87e915448371e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fc4decdf078a2ce9ba2c9fecb2a9896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74631c182d5ae81bc91e09f6806b6686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca261b03cdd7a320226f80a12085fd6 |
publicationDate |
2018-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
FR-3057776-A1 |
titleOfInvention |
LEPISTA FLACCIDA FOR USE IN THE TREATMENT OF DISEASE DUE TO NON-SENSE MUTATION |
abstract |
The invention relates to the use of Lepista flaccida for use in the treatment of a disease caused by a nonsense mutation of a gene leading to the premature introduction of a UGA and / or UAA stop codon. It also relates to an extract of Lepista flaccida obtained by maceration or infusion of Lepista flaccida in a solvent. It also relates to this extract of Lepista flaccida intended to be used in the treatment of a disease due to a nonsense mutation of a gene leading to the premature introduction of a UGA and / or UAA stop codon. It also relates to a method of therapeutic treatment comprising a step of administering Lepista flaccida or an extract of Lepista flaccida or a pharmaceutical composition comprising this extract of Lepista flaccida. The invention finds application in the pharmaceutical field, in particular for the treatment of diseases due to a nonsense mutation of a gene leading to the introduction of a UGA and / or UAA stop codon. |
priorityDate |
2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |